LXEO Lexeo Therapeutics, Inc.
$2.87▲ +6.30%
Healthcare
Other
After hours
$2.90▲ +1.05%
Oct 27, 4:22 PM ET
Volume 2.68M
Avg Volume (10D) 1.38M
Key Metrics & Fundamentals
Market Cap
$235.59M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.55 - 10.99
% vs 50 MA
-25.89%
% vs 200 MA
-45.65%
RSI-14
39.5
MACD Histogram
+0.0400
Beta (1Y vs SPY)
2.01
Free Cash Flow
-$17.60M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$25.28M
COGS
–
Operating Exp
$28.02M
Operating Income
-$28.02M
EBIT
-$28.02M
Pretax Income
-$25.87M
Net Income
-$25.87M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
Lexeo Therapeutics Maps Gene Therapy Milestones, Eyes Key 2027 Readout
MarketBeat · Oct 25, 2026 10:02 AM ET
Lexeo Therapeutics Eyes NSVT Data as Key Test for LX2020 Gene Therapy
MarketBeat · Oct 24, 2026 3:02 AM ET
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
GlobeNewswire · Oct 19, 2026 7:00 AM ET
Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
GlobeNewswire · Oct 8, 2026 7:00 AM ET
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
GlobeNewswire · Oct 1, 2026 9:00 AM ET
Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
PR Newswire · Sep 23, 2026 8:00 AM ET
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
GlobeNewswire · Sep 23, 2026 7:00 AM ET
Lexeo Therapeutics to Acquire Mantle Therapeutics for Up to $21.3 Million; Enters Three Research Collaborations
MT Newswires · Sep 22, 2026 8:12 AM ET
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
GlobeNewswire · Sep 22, 2026 7:00 AM ET
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
GlobeNewswire · Sep 2, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LXEO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.